Key result
Expedited invasive strategy lacks sufficient evidence to support routine use in NACS.
Why the study?
The optimal timing of coronary angiography in patients with high-risk non-ST-segment elevation acute coronary syndromes remains uncertain due to limited and mainly observational data.
Does an expedited invasive strategy improve outcomes compared to deferred angiography in patients with high-risk non-ST-segment elevation acute coronary syndromes?
Population
Patients with high-risk non-ST-segment elevation acute coronary syndromes
Comparison
Expedited early invasive strategy vs deferred angiography
Design
Review including observational analyses and one small randomized clinical trial
Authors
Loading...
Current evidence does not support routine expedited invasive strategy in NSTE-ACS; larger RCTs needed to confirm viability.
Does an expedited invasive strategy improve outcomes compared to deferred angiography in patients with high-risk non-ST-segment elevation acute coronary syndromes?
Current evidence is insufficient to recommend a routine expedited invasive strategy for high-risk NSTE-ACS, though it remains a viable approach.
Pierluigi Tricoci (2008) conducted a review in high-risk non-ST-segment elevation acute coronary syndromes. Expedited invasive strategy (early coronary angiography) vs. Deferred angiography was evaluated. An expedited invasive strategy for non-ST-segment elevation acute coronary syndrome may be a viable approach, though current evidence is insufficient to recommend its routine use.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: